Limba
|
GSK1292263 is a novel GPR119agonist, showing potential for the treatment of type 2 diabetes. Phase 2.
Price | 1.262,00 RON (preturile sunt fara TVA) |
---|---|
Description |
GSK1292263 is a novel GPR119agonist, showing potential for the treatment of type 2 diabetes. Phase 2. |